Company Announcements

IQE plc: Result of AGM

Source: RNS
RNS Number : 4853Q
IQE PLC
28 June 2022
 

IQE plc

 

Cardiff, UK

28 June 2022

 

 

Results of Annual General Meeting

 

 

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, is pleased to announce that at its 2022 Annual General Meeting, held today in London, UK, all resolutions were duly passed.

Votes were cast as shown below:

 

Ordinary Resolution 1: Receipt of Directors' Report & Financial Statements

For: 437,855,113 - 99.99%

Against: 32,774 - 0.01%

Withheld: 42,447

 

Ordinary Resolution 2: Approval of the Directors' Annual Report on Remuneration

For: 433,500,728 - 99.00%

Against: 4,376,693 - 1.00%

Withheld: 52,913

 

Ordinary Resolution 3: To re-elect Phil Smith

For: 436,091,562 - 99.60%

Against: 1,736,260 - 0.40%

Withheld: 102,512

 

Ordinary Resolution 4: To re-elect Americo Lemos

For: 437,679,640 - 99.97%

Against: 148,382 - 0.03%

Withheld: 102,312

 

Ordinary Resolution 5: To re-elect Tim Pullen

For: 437,268,044 - 99.87%

Against: 555,320 - 0.13%

Withheld: 106,970

 

Ordinary Resolution 6: To re-elect Carol Chesney

For: 436,120,667 - 99.61%

Against: 1,700,879 - 0.39%

Withheld: 108,788

 

Ordinary Resolution 7: To re-elect Victoria Hull

For: 437,493,735 - 99.92%

Against: 329,989 - 0.08%

Withheld: 106,610

 

Ordinary Resolution 8: To re-elect Andrew Nelson

For: 436,839,051 - 99.78%

Against: 984,673 - 0.22%

Withheld: 106,610

 

Ordinary Resolution 9: To re-elect Derek Jones

For: 436,234,583 - 99.64%

Against: 1,560,337 - 0.36%

Withheld: 135,414

Ordinary Resolution 10:  Reappointment of auditor

For: 437,474,069 - 99.93%

Against: 314,665 - 0.07%

Withheld: 141,600

 

Ordinary Resolution 11:  Directors' authority to allot shares

For: 437,187,043 - 99.86%

Against: 631,410 - 0.14%

Withheld: 111,881

 

Special Resolution 12:  Disapplication of pre-emption rights

For: 430,661,706 - 98.40%

Against: 7,001,220 - 1.60%

Withheld: 267,408

 

Special Resolution 13:  Additional authority for disapplication of pre-emption rights

For: 430,661,424 - 98.40%

Against: 6,989,625 - 1.60%

Withheld: 279,285

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Tim Pullen

Amy Barlow

           

Peel Hunt LLP (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Edward Knight

Paul Gillam

James Smith

           

Citigroup Global Markets Limited (Joint Broker)

+44 (0) 20 7986 4000

Christopher Wren

Peter Catterall

 

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Antonia Pollock: +44 (0) 7789 954 356

 

embedded PR (Non-Financial PR)

Europe:  Anja-Maria Hastenrath

Phone:  +49 89 / 64913634-1

E-mail: ah@embedded-pr.de

 

United States:  Cynthia Hoye

Phone:  +1 408-858-2602

E-mail: ch@embedded-pr.com

 

 

ABOUT IQE

http://iqep.com

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

·    handset devices

·    global telecoms infrastructure

·    connected devices

·    3D Sensing

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.


IQE is headquartered in Cardiff UK, with c. 685 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGEAFKPAFAAEFA